Trials / Completed

CompletedNCT00273442

Assessing Cosopt Switch Patients

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 60 (planned)

Sponsor: Pharmaceutical Research Network · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy.

Conditions

Ocular Hypertension
Open-Angle Glaucoma
Exfoliation Syndrome
Glaucoma, Pigmentary

Interventions

Type	Name	Description
DRUG	timolol maleate
DRUG	dorzolamide/timolol maleate fixed combination

Timeline

Start date: 2005-11-01
Completion: 2007-04-01
First posted: 2006-01-09
Last updated: 2008-11-19

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00273442. Inclusion in this directory is not an endorsement.